GALMED PHARMACEUTICALS LTD - SHS (GLMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2023

Type / Class
Equity / SHS
Symbol
GLMD on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$872,497 0
2023 Q1 2,061,931 $878,347 -$163,815 $0.43 21
2022 Q4 2,425,154 $1,213,076 -$48,085 $0.50 20
2022 Q3 2,580,502 $802,223 +$15,313 $0.31 21
2022 Q2 2,516,484 $1,694,399 -$627,914 $0.66 19
2022 Q1 2,809,117 $4,465,975 -$1,934,033 $1.59 21
2021 Q4 3,874,365 $7,051,550 -$758,076 $1.82 23
2021 Q3 4,229,422 $11,801,975 -$1,638,170 $2.79 23
2021 Q2 4,813,565 $14,631,600 -$2,729,925 $3.04 24
2021 Q1 5,663,778 $19,425,290 -$2,058,417 $3.43 30
2020 Q4 6,264,175 $19,483,000 -$1,308,952 $3.11 21
2020 Q3 6,647,415 $23,430,530 -$4,128,338 $3.53 23
2020 Q2 7,419,865 $35,438,780 +$2,993,480 $4.78 24
2020 Q1 7,059,412 $24,419,460 +$4,270,544 $3.46 31
2019 Q4 5,887,801 $34,031,780 -$2,917,036 $5.78 31
2019 Q3 6,302,684 $30,118,780 -$11,278,740 $4.78 30
2019 Q2 7,734,770 $56,852,350 +$2,332,787 $7.35 33
2019 Q1 7,416,360 $60,589,170 -$1,338,068 $8.17 34
2018 Q4 7,647,947 $52,233,830 -$1,016,802 $6.83 42
2018 Q3 7,613,542 $103,481,580 -$17,400,860 $13.58 37
2018 Q2 8,330,591 $99,133,900 +$76,692,902 $11.90 42
2018 Q1 2,654,611 $14,778,000 -$1,301,577 $5.57 19
2017 Q4 2,729,302 $24,961,000 +$7,068,833 $9.15 19
2017 Q3 1,254,222 $11,446,000 +$1,872,100 $9.10 11
2017 Q2 1,051,132 $6,519,000 +$851,792 $6.20 10
2017 Q1 919,326 $4,494,000 +$227,064 $4.88 8
2016 Q4 893,963 $3,139,000 +$620,470 $3.51 11
2016 Q3 706,240 $3,135,000 +$690,785 $4.43 17
2016 Q2 549,770 $2,468,000 -$816,860 $4.49 16
2016 Q1 722,308 $3,558,000 -$484,383 $4.93 18
2015 Q4 778,961 $5,928,000 -$205,949 $7.61 20
2015 Q3 806,107 $5,987,000 -$288,866 $7.42 20
2015 Q2 830,694 $8,356,000 -$1,170,372 $10.06 22
2015 Q1 948,493 $8,931,000 +$741,691 $9.41 22
2014 Q4 930,177 $5,393,000 -$2,053,190 $5.80 16
2014 Q3 1,163,288 $10,003,000 -$6,301,378 $8.60 19
2014 Q2 1,819,991 $17,725,000 +$1,007,435 $9.74 20
2014 Q1 1,678,963 $19,258,000 +$19,258,000 $11.47 20